On Tuesday, there are stocks with unusual volume. Let's take a look.
By Mill Chart
Last update: May 14, 2024
In today's session, there are stocks attracting attention with their unusual volume. Let's take a closer look.
Top unusual volume stocks
| Ticker | Change | Comment |
|---|---|---|
| CCLD | -12.07% | CARECLOUD INC's (NASDAQ:CCLD) traded a high volume of 2.88M shares. The share price has dropped by 12.07% in today's session. The average volume over the last 50 days is 1.9M, making today's volume 51.77% above the average. This signifies a notable change in market participation. The company's earnings where released Yesterday. |
| KOSS | 33.18% | KOSS CORP (NASDAQ:KOSS) has an unusual volume of 16.54M shares today. NASDAQ:KOSS is experiencing an advancement of 33.18% in its share price today. Compared to the average daily volume of the past 50 days, the current volume is 4.0K% above, suggesting an unusual level of trading activity. |
| ACIU | 2.42% | AC IMMUNE SA's (NASDAQ:ACIU) traded a high volume of 2.26M shares. NASDAQ:ACIU is experiencing an advancement of 2.42% in its share price today. Compared to the average daily volume of the past 50 days, the current volume is 169.0% above, suggesting an unusual level of trading activity. A press release (AC Immune Reports First Quarter 2024 Financial Results and Provides a Corporate Update) was released yesterday. |
| TMCI | 12.58% | TREACE MEDICAL CONCEPTS INC (NASDAQ:TMCI) has an unusual volume of 2.81M shares today. Shares are rising by 12.58%. Compared to the average daily volume of the past 50 days, the current volume is 220.0% above, suggesting an unusual level of trading activity. |
| NVAX | 7.32% | 37.76M shares of NOVAVAX INC (NASDAQ:NVAX) have been traded so far today. NASDAQ:NVAX is experiencing an advancement of 7.32% in its share price today. The average daily volume over the past 50 days is 10.35M. Hence, the current volume is 265.0% above the average volume, indicating a deviation from the usual trading pattern. |
| KITT | 18.3% | So far 15.81M shares of NAUTICUS ROBOTICS INC (NASDAQ:KITT) have traded in today's session. Shares in NASDAQ:KITT are on the rise, with a gain of 18.3% observed in today's trading session. This volume is 986.0% above the average 50 day volume. |
| MGNX | 3.42% | MACROGENICS INC (NASDAQ:MGNX) has an unusual volume of 3.62M shares today. Shares are rising by 3.42%. With an average volume of 2.58M over the past 50 days, the current volume is 40.41% above the average. This deviation signals a potential shift in market dynamics. Yesterday the company had a press release: Kirby McInerney LLP Announces Investigation of Shareholder Claims Against MacroGenics, Inc. (MGNX). |
| INKT | 9.18% | So far 339.82K shares of MINK THERAPEUTICS INC (NASDAQ:INKT) have traded in today's session. NASDAQ:INKT is showing a positive trend today, with a price increase of 9.18%. With an average daily volume of 201.94K over the past 50 days, today's volume is 68.27% above the average, indicating a potential shift in market sentiment. yesterday the company released their earnings. A press release (MiNK Reports First Quarter 2024 Results) was released earlier today. |
| RPHM | 0.63% | Today's trading session witnessed an unusual volume of 1.21M shares for RENEO PHARMACEUTICALS INC (NASDAQ:RPHM). The market is favoring NASDAQ:RPHM today, as its share price records a notable increase of 0.63%. The average volume over the last 50 days is 258.41K, making today's volume 367.0% above the average. This signifies a notable change in market participation. A press release (RPHM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Reneo Pharmaceuticals, Inc. Is Fair to Shareholders) was released yesterday. |
| AGS | 0.35% | PLAYAGS INC (NYSE:AGS) has an unusual volume of 630.04K shares today. NYSE:AGS is experiencing an advancement of 0.35% in its share price today. With an average volume of 519.02K over the past 50 days, the current volume is 21.39% above the average. This deviation signals a potential shift in market dynamics. |
For the full unusual volume stocks list go to our unusual volume stocks screener.
MINK THERAPEUTICS INC
NASDAQ:INKT (5/31/2024, 7:00:02 PM)
0.97
+0.01 (+1.04%)
INKT News
10 days ago - MiNK TherapeuticsMiNK Presents AgenT-797 Clinical Activity in Immune-Compromised Transplant Patient with Severe ARDS at ATS Annual MeetingNEW YORK, May 22, 2024 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery,...
18 days ago - ChartmillOn Tuesday, there are stocks with unusual volume. Let's take a look.In today's session, there are stocks attracting attention with their unusual volume. Let's take a closer look.
18 days ago - InvestorPlaceINKT Stock Earnings: MiNK Therapeutics Beats EPS for Q1 2024INKT stock results show that MiNK Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.
18 days ago - MiNK TherapeuticsMiNK Reports First Quarter 2024 ResultsCompleted $5.8 million private placement financing at 25% premium Upcoming presentation of agenT-797 in severe respiratory distress at the American...
19 days ago - ChartmillThe market is buzzing with gapping stocks on Monday. Let's uncover which stocks are experiencing notable gaps during today's session.In today's session, there are notable price gaps in the US markets on Monday. Take a closer look at the stocks that are gap up and gap down.
19 days ago - ChartmillTop movers in Monday's pre-market sessionAs the US market prepares to open on Monday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
19 days ago - MiNK TherapeuticsMiNK Therapeutics Announces $5.8 Million Private Placement and Appointment of Board ObserverFinancing of $5.8 Million at a 25% premium will help advance the clinical development of MiNK-215, an armored-FAP-CAR-iNKTGKCC, LLC joins as a new investor...
a month ago - MiNK TherapeuticsMiNK to Provide Corporate Update and First Quarter 2024 Financial ReportNEW YORK, April 30, 2024 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery,...
